Vijaya Diagnostic Centre Share Price

Overview
Recos
News
Analysis
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About

Vijaya Diagnostic Centre Share Price

1,287.208.00 (0.63%)

Closed
As On: 12 Jun, 2026, 03:54 PM IST
As On: 12 Jun, 2026, 03:40 PM IST

Sector: Hospitals & All...
Industry: Diagnostics

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Try ETMarkets GPTNEW

Open	1,285.00
High	1,295.90
Low	1,252.00
Prev Close	1,279.20
Volume	2,82,698
VWAP(₹)	1,264.26

Key Metrics

PE Ratio(x)	76.68
EPS - TTM(₹)	16.79
MCap(₹ Cr.)	13,244.87
MCap Rank	13
PB Ratio(x)	13.65
Div Yield(%)	0.16
Face Value(₹)	1.00
52W High(₹)	1,427.80
52W Low(₹)	848.00
MCap/Sales	10.89
Beta(1 Month)	-
BV/Share(₹)	93.02

Vijaya Diagnostic share price insights

Employee & Interest Expense
Company has spent 4.08% of its operating revenues towards interest expenses and 16.06% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
Buy Signal: Green flag for Bulls
Weekly stochastic crossover appeared on week ending Jun 12, 2026. Average price gain of 11.16% within 7 weeks of this signal in last 10 years.
Vijaya Diagnostic Share Price Update
Vijaya Diagnostic Centre Ltd. share price moved up by 0.63% from its previous close of Rs 1,279.20. Vijaya Diagnostic Centre Ltd. stock last traded price is 1,287.20
Share Price Value
Today/Current/Last 1,287.201,288.20
Previous Day 1,279.201,278.75

Found Insights useful?

Vijaya Diagnostic Share Price Returns

1 Day	0.63%
1 Month	0.63%
3 Months	34.71%
1 Year	34.1%
3 Years	229.59%
5 Years	N.A.

Vijaya Diagnostic Share Recommendations

Mean recosCurrent

BUY

8 Analysts

Strong
SellSellHoldBuyStrong
Buy

Analyst Trends

Ratings	Current	1W Ago	1M Ago	3M Ago
Strong Buy	4	4	4	4
Buy	2	2	1	2
Hold	2	2	2	1
Sell	-	-	1	1
Strong Sell	-	-	-	-
# Analysts	8	8	8	8

Recent Recos

Target₹590
OrganizationICICI Securities
REDUCE

Target₹480
OrganizationYes Securities
ADD

Target₹505
OrganizationJM Financial
BUY

View all Stock Recommendations

News & Analysis

View all Vijaya Diagnostic Share News & Announcements

Financials

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	221.78	210.31	207.81	195.10	178.79
Total Income Growth (%)	5.45	1.20	6.51	9.12	2.94
Total Expenses	148.19	143.49	142.00	135.41	124.23
Total Expenses Growth (%)	3.27	1.05	4.87	9.00	3.39
EBIT	73.59	66.82	65.81	59.69	54.56
EBIT Growth (%)	10.14	1.53	10.25	9.40	1.94
Profit after Tax (PAT)	47.93	43.18	43.28	38.34	34.64
PAT Growth (%)	11.01	-0.25	12.90	10.69	-1.48
EBIT Margin (%)	33.18	31.77	31.67	30.60	30.52
Net Profit Margin (%)	21.61	20.53	20.83	19.65	19.37
Basic EPS (₹)	4.66	4.20	4.21	3.76	3.38

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	213.49	198.63	194.51	182.27	165.53
Total Income Growth (%)	7.48	2.12	6.71	10.11	2.66
Total Expenses	136.49	131.65	130.24	123.80	113.84
Total Expenses Growth (%)	3.68	1.08	5.20	8.75	2.90
EBIT	77.00	66.98	64.26	58.47	51.69
EBIT Growth (%)	14.96	4.23	9.91	13.11	2.14
Profit after Tax (PAT)	52.65	44.21	42.70	38.39	33.12
PAT Growth (%)	19.09	3.54	11.23	15.91	-1.23
EBIT Margin (%)	36.07	33.72	33.04	32.08	31.23
Net Profit Margin (%)	24.66	22.26	21.95	21.06	20.01
Basic EPS (₹)	5.12	4.30	4.15	3.74	3.23

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	835.00	699.71	568.62	473.37	475.20
Total Revenue Growth (%)	19.34	23.05	20.12	-0.38	22.29
Total Expenses	602.32	505.52	407.89	359.86	327.82
Total Expenses Growth (%)	19.15	23.93	13.35	9.78	18.57
Profit after Tax (PAT)	172.98	143.08	118.83	84.63	109.68
PAT Growth (%)	20.90	20.41	40.40	-22.84	29.83
Operating Profit Margin (%)	32.65	32.42	33.72	29.27	35.43
Net Profit Margin (%)	21.24	20.99	21.69	18.42	23.72
Basic EPS (₹)	16.81	13.16	11.62	8.29	10.76

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	790.59	646.44	546.46	464.15	463.80
Total Revenue Growth (%)	22.30	18.30	17.73	0.08	22.65
Total Expenses	554.20	464.11	391.94	352.88	319.42
Total Expenses Growth (%)	19.41	18.41	11.07	10.48	18.94
Profit after Tax (PAT)	178.31	135.01	114.60	83.23	108.10
PAT Growth (%)	32.07	17.81	37.69	-23.01	30.53
Operating Profit Margin (%)	34.90	33.05	33.94	29.39	35.62
Net Profit Margin (%)	23.29	21.52	21.82	18.51	23.97
Basic EPS (₹)	17.33	13.16	11.21	8.16	10.60

All figures in Rs Cr, unless mentioned otherwise

Insights

Employee & Interest Expense
Company has spent 4.08% of its operating revenues towards interest expenses and 16.06% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	1,507.05	1,273.62	982.75	853.41	713.46
Total Assets Growth (%)	18.33	29.60	15.16	19.62	31.82
Total Liabilities	549.90	474.47	322.84	306.78	243.92
Total Liabilities Growth (%)	15.90	46.97	5.24	25.77	34.02
Total Equity	957.15	799.14	659.91	546.63	469.54
Total Equity Growth (%)	19.77	21.10	20.72	16.42	30.71
Current Ratio (x)	2.60	1.89	2.90	4.17	4.08
Total Debt to Equity (x)	0.00	0.00	0.00	0.00	0.00
Contingent Liabilities	0.00	21.32	41.99	25.07	50.68

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	1,459.75	1,223.93	962.14	850.06	710.83
Total Assets Growth (%)	19.27	27.21	13.18	19.59	33.40
Total Liabilities	516.30	440.41	308.82	304.97	240.85
Total Liabilities Growth (%)	17.23	42.61	1.26	26.62	39.78
Total Equity	943.45	783.53	653.32	545.09	469.98
Total Equity Growth (%)	20.41	19.93	19.86	15.98	30.35
Current Ratio (x)	2.77	1.93	2.97	4.17	4.17
Total Debt to Equity (x)	0.00	0.00	0.00	0.00	0.00
Contingent Liabilities	0.00	6.24	41.99	25.07	50.68

All figures in Rs Cr, unless mentioned otherwise

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	270.59	224.47	183.30	164.61	158.00
Net Cash used in Investing Activities	-174.22	-181.87	-142.31	-109.57	-123.06
Net Cash flow from Financing Activities	-69.49	-52.05	-44.55	-41.91	-30.57
Net Cash Flow	26.88	-9.45	-1.93	13.13	4.36
Closing Cash & Cash Equivalent	39.68	12.80	22.25	24.18	11.05
Closing Cash & Cash Equivalent Growth (%)	209.94	-42.46	-7.98	118.80	65.28
Total Debt/ CFO (x)	0.00	0.00	0.00	0.00	0.00

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	255.96	206.61	174.77	162.64	155.51
Net Cash used in Investing Activities	-165.84	-165.37	-139.15	-108.48	-126.72
Net Cash flow from Financing Activities	-63.20	-46.84	-43.35	-41.26	-24.72
Net Cash Flow	26.92	-5.60	-7.73	12.90	4.08
Closing Cash & Cash Equivalent	37.76	9.97	15.56	23.29	10.39
Closing Cash & Cash Equivalent Growth (%)	278.88	-35.96	-33.17	124.15	64.58
Total Debt/ CFO (x)	0.00	0.00	0.00	0.00	0.00

All figures in Rs Cr, unless mentioned otherwise

Insights

Decrease in Cash from Investing
Company has used Rs 174.22 cr for investing activities which is an YoY decrease of 4.21%. (Source: Consolidated Financials)

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	18.07	17.98	18.08	15.53	23.42
Return on Capital Employed (%)	19.22	19.88	20.30	17.07	25.30
Return on Assets (%)	11.47	11.23	12.09	9.91	15.37
Interest Coverage Ratio (x)	10.77	10.90	10.08	9.37	13.16
Asset Turnover Ratio (x)	0.59	0.60	0.60	0.59	0.74
Price to Earnings (x)	51.28	72.46	54.95	47.39	40.82
Price to Book (x)	9.26	12.99	9.89	7.33	9.53
EV/EBITDA (x)	24.63	35.29	26.60	19.77	19.74
EBITDA Margin (%)	43.93	42.78	44.12	42.71	46.82

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	18.89	17.23	17.54	15.26	23.00
Return on Capital Employed (%)	19.85	19.35	19.88	16.82	24.80
Return on Assets (%)	12.21	11.03	11.91	9.79	15.20
Interest Coverage Ratio (x)	11.28	10.89	9.85	9.27	13.09
Asset Turnover Ratio (x)	0.57	0.57	0.58	0.58	0.73
Price to Earnings (x)	49.75	76.92	56.82	48.08	41.32
Price to Book (x)	9.40	13.19	9.95	7.33	9.50
EV/EBITDA (x)	25.35	37.86	27.55	20.06	20.10
EBITDA Margin (%)	45.41	43.34	44.50	43.04	47.19

Found Financials useful?

Share Price Forecast

Exclusively for ETPrime

REVENUE
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
EARNINGS
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
PRICE
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP

Technicals

Buy/Sell Signals
Stochastic Crossover
Bullish signal on weekly chart
Appeared on: 12 Jun 2026
Region: Overbought (Above 80)
Last Signal 2 Apr 2026 (Gain 36.45%)
Average price gain of 11.16% within 7 weeks of Bullish signal in last 10 years
20 Day EMA Crossover
Bullish signal on daily chart
Appeared on: 11 Jun 2026
20D EMA: 1273.17
Last Signal 7 Apr 2026 (Gain 7.60%)
Average price gain of 4.25% within 7 days of Bullish signal in last 5 years
14 Day EMA Crossover
Bearish signal on daily chart
Appeared on: 10 Jun 2026
14D EMA: 1289.10
Last Signal 1 Jun 2026 (Loss -0.02%)
Average price decline of -3.40% within 7 days of Bearish signal in last 5 years
Price Analysis
44%
Positive Movement
since 1st Jan 2005
on basis
56%
Negative Movement
since 1st Jan 2005
on basis
Exclude
Global Meltdown1st Jan 2008 to 10th Nov 2008
Covid Crisis1st Feb 2020 to 31st Mar 2020
Pivot Levels
R1 1304.73 Pivot
1278.37
S1 1260.83
R2 1322.27 S2 1234.47
R3 1366.17 S3 1190.57
Average True Range
5 Days 14 Days 28 Days
57.12 58.51 52.02

Found Technicals useful?

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Vijaya Diagnostic	76.68	13.84	18.07	19.22	11.47	20.60	32.65	21.24	16.81	2.60	0.00	0.00
Dr Lal Pathlabs	53.16	10.56	20.12	26.78	16.04	11.51	26.13	18.45	30.24	3.48	0.00	0.00
Metropolis Health	57.90	7.22	12.55	16.22	8.88	12.70	17.78	11.61	9.19	1.40	0.01	0.05
Thyrocare Tech.	51.63	14.36	27.84	34.59	21.81	16.32	26.59	19.47	10.27	3.39	0.00	0.00
Krsnaa Diagnostics	17.09	1.77	10.34	10.64	5.56	17.05	21.32	13.13	31.29	2.68	0.55	3.73
Add More

Annual Ratios (%)

Choose from Peers

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

Shareholding Pattern

Total Shareholdings
Category No. of Shares Percentage % Change QoQ
Promoters 5,40,33,156 52.51 % -0.09
Pledge 8,00,000 1.48 % 0.00
FII 1,37,66,187 13.38 % -1.71
DII 3,08,00,050 29.93 % 1.32
MF 2,99,05,125 29.06 % 1.07
Others 42,97,335 4.18 % 0.48
QoQ Change
Category Mar 2026 Dec 2025 Sep 2025 Jun 2025
Promoters 52.51 52.60 52.60 52.63
Pledge 1.48 1.48 0.00 0.00
FII 13.38 15.10 18.27 19.56
DII 29.93 28.60 25.34 24.07
Mutual Funds 29.06 27.98 24.80 23.55
Others 4.18 3.69 3.78 3.74

Mutual Funds Ownership

MF Ownership as on 30 April 2026

Kotak Small Cap Direct-G
Equity: Small Cap
2
- 645.13
  Amount Invested (in Cr.)
- 3.7%
  % of AUM
- -2.56
  % Change (MoM basis)
Nippon India Multi Cap Direct-G
Equity: Multi Cap
4
- 482.39
  Amount Invested (in Cr.)
- 0.92%
  % of AUM
- 2.34
  % Change (MoM basis)
Nippon India Pharma Direct-G
Equity: Sectoral-Pharma
3
- 280.90
  Amount Invested (in Cr.)
- 3.36%
  % of AUM
- -13.86
  % Change (MoM basis)

View all Mutual Fund Schemes

Vijaya Diagnostic Top Searches

Corporate Actions

Recent
Board Meeting
Quarterly Results
Feb 06, 2026
Board Meeting
Quarterly Results
Oct 27, 2025
General Meeting
-
Aug 12, 2025

Announced on	Meeting on
Feb 06, 2026	Feb 13, 2026
Quarterly Results
Oct 27, 2025	Nov 04, 2025
Quarterly Results
Jul 18, 2025	Jul 28, 2025
Quarterly Results
May 06, 2025	May 12, 2025
Audited Results & Final Dividend
Feb 06, 2025	Feb 12, 2025
Quarterly Results & Others

Dividends
Announced on Ex-Date Dividend%
May 12, 2025 Aug 29, 2025 200%
May 08, 2024 Aug 30, 2024 100%
May 29, 2023 Sep 13, 2023 100%
May 26, 2022 Sep 20, 2022 100%
Bonus
No Data Available
Splits
No Data Available
Rights
No Data Available
AGM/EGM Meetings
Announced on Meeting on
Aug 12, 2025 Sep 05, 2025
-
Mar 25, 2025 Apr 25, 2025
-
Aug 19, 2024 Sep 06, 2024
-
May 29, 2023 Sep 20, 2023
-
May 26, 2022 Sep 28, 2022
-

About Vijaya Diagnostic

Vijaya Diagnostic Centre Ltd., incorporated in the year 2002, is a Small Cap company (having a market cap of Rs 13,244.87 Crore) operating in Hospitals & Allied Services sector.

Vijaya Diagnostic Centre Ltd. key Products/Revenue Segments include Hospital Services, Scrap and Other Operating Revenue for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 221.78 Crore, up 5.45 % from last quarter Total Income of Rs 210.31 Crore and up 24.04 % from last year same quarter Total Income of Rs 178.79 Crore. Company has reported net profit after tax of Rs 47.93 Crore in latest quarter.

The company’s top management includes Dr.Sura Surendranath Reddy, Ms.Sura Suprita Reddy, Mr.Sunil Chandra Kondapally, Mrs.Sura Geeta Reddy, Mr.Chavali Satyanarayana Murthy, Dr.Duvvur Nageshwar Reddy, Dr.(Ms.)Manjula Anagani, Mr.Shekhar Prasad Singh, Mr.S Ramchandra Reddy, Ms.Hansraj Singh Rajput. Company has B S R & Associates LLP as its auditors. As on 31-03-2026, the company has a total of 10.29 Crore shares outstanding.

Vijaya Diagnostic Share Price Today is Rs. 1287.20. On previous day, the Vijaya Diagnostic Share Price (NSE) closed at Rs. 1279.2, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 52.51% of the stake in Vijaya Diagnostic shares, out of which 1.48% was pledged. On the same date, foreign institutional investors' (FII) holdings of Vijaya Diagnostic stocks was 13.38% as compared to 15.1% in Dec 2025 with decrease of 1.72%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 29.93% as compared to 28.6% in Dec 2025 with increase of 1.33%. Out of the total DII holdings in Vijaya Diagnostic shares 29.06% was held by mutual funds. The rest including public held is 4.18%. Vijaya Diagnostic stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Vijaya Diagnostic Dividend: Ever since 2002, Vijaya Diagnostic dividends has been paid out around 5 times. As on 12 Jun, 2026, 03:54 PM IST, The overall dividend yield for Vijaya Diagnostic stands at 0.16%. The last dividend paid was on August 29, 2025 (Rs. 2.0). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 16.79.

Vijaya Diagnostic Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.

Stock Forecast:
After showing 221.78 Cr. of sales and 5.45% of quarterly net profit, there have been multiple ups and downs in the Vijaya Diagnostic stock prices in the past few weeks. For example, Vijaya Diagnostic stock price on 5th of June 2026 was around Rs. 1372.4. Vijaya Diagnostic share price now stands at an average of Rs. 1287.20. Judging by last week's performance, stock is in down trend.

Vijaya Diagnostic has a median target price of Rs. 1385.75 in 12 months by 8 analysts. They have provided a high estimate of Rs. 1517.0 and low estimate of Rs. 1200.0 for Vijaya Diagnostic share.

Historical Prices and Performance:
Vijaya Diagnostic, incorporated in 2002 is a Mid Cap company (with a market cap of Rs. 13244.87) operating in Hospitals & Allied Services sector.
The Return of Equity (ROE) in last five financial years given by Vijaya Diagnostic stock was 18.07%, 17.98%, 18.08%, 15.53% and 23.42% respectively.
The Vijaya Diagnostic share gave a 3 year return of 229.59% as compared to Nifty 50 which gave a return of 26.99%.
Vijaya Diagnostic announced 200.0% final dividend on August 29, 2025.

Key Metrics:
PE Ratio of Vijaya Diagnostic is 76.68
Prices/Sales Ratio of Vijaya Diagnostic is 10.89
Price/Book Ratio of Vijaya Diagnostic is 13.84

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Vijaya Diagnostic, major competitors and peers include Dr Lal Pathlabs, Metropolis Health, Thyrocare Tech. and Krsnaa Diagnostics. As of Dec 2025, the dividend yield of Vijaya Diagnostic stands at 0.16% while Dr Lal Pathlabs, Metropolis Health, Thyrocare Tech. and Krsnaa Diagnostics stand at 1.28%, 0.0%, 2.65% and 0.0% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 76.68 and 13.84 respectively.

Leadership of Vijaya Diagnostic :
Hansraj Singh Rajput is Co. Secretary & Compl. Officer
S Ramchandra Reddy is Interim Chief Financial Officer
Sura Surendranath Reddy is Executive Chairman
Sura Suprita Reddy is Managing Director & CEO
Sunil Chandra Kondapally is Executive Director
Sura Geeta Reddy is Non Exe.Non Ind.Director
Chavali Satyanarayana Murthy is Ind. Non-Executive Director
Shekhar Prasad Singh is Ind. Non-Executive Director
Manjula Anagani is Ind. Non-Executive Director
Duvvur Nageshwar Reddy is Ind. Non-Executive Director

Show More

Industry

Key Indices Listed On

Nifty 500, BSE SmallCap, BSE Healthcare, BSE AllCap, Nifty MidSmallcap400 50:50

Address

No. 6-3-883/F, Ground Floor,FPA Building,Near Topaz building,Hyderabad, Telangana - 500082

Contact

cs@vijayadiagnostic.in

http://www.vijayadiagnostic.com

Executive Leadership

SS

Sura Surendranath Reddy

Executive Chairman

SS

Sura Suprita Reddy

Managing Director & CEO

SC

Sunil Chandra Kondapally

Executive Director

SG

Sura Geeta Reddy

Non Exe.Non Ind.Director

Show More

Auditors

B S R & Co. LLP

B S R & Associates LLP

FAQs about Vijaya Diagnostic share

1. What is Vijaya Diagnostic share price and what are the returns for Vijaya Diagnostic share?
As on 12 Jun, 2026, 03:54 PM IST Vijaya Diagnostic share price is up by 0.63% basis the previous closing price of Rs 1,269.7. Vijaya Diagnostic share price is Rs 1,287.20. Return Performance of Vijaya Diagnostic Shares:
- 1 Week: Vijaya Diagnostic share price moved down by 6.21%
2. What is the PE & PB ratio of Vijaya Diagnostic?
The PE ratio of Vijaya Diagnostic stands at 76.2, while the PB ratio is 13.75.
3. What has been highest price of Vijaya Diagnostic share in last 52 weeks?
52 Week high of Vijaya Diagnostic share is Rs 1,427.80 while 52 week low is Rs 848.00
4. What are the returns for Vijaya Diagnostic share?
Return Performance of Vijaya Diagnostic Shares:
- 1 Week: Vijaya Diagnostic share price moved down by 6.21%
5. What's the market capitalization of Vijaya Diagnostic?
Within the Hospitals & Allied Services sector, Vijaya Diagnostic stock has a market cap rank of 13. Vijaya Diagnostic has a market cap of Rs 13,244.87 Cr.

Top Gainers

As on 04:06 PM | 12 Jun 2026

84.57

14.09 (20.00%)

Authum Investment

530.15

70.20 (15.27%)

Tata Teleservices

46.44

4.29 (10.18%)

152.45

13.87 (10.01%)

Netweb Technologies

4,587.40

396.00 (9.45%)

Top Losers

As on 03:58 PM | 12 Jun 2026

1,375.70

-46.80 (-3.29%)

417.80

-11.56 (-2.70%)

246.20

-6.41 (-2.54%)

1,429.20

-35.90 (-2.46%)

OneSource Specialty

1,612.50

-38.91 (-2.36%)

Equity Quick Links

Top Gainers
Top Losers
Hourly gainers
Hourly losers
Sensex
Nifty
NSE
BSE

Midcap stocks
Smallcap stocks
Largecap stocks
Sensex
Nifty
NSE
BSE
MCX Live

More from Markets

IPO
Stock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.